Skip to content

Research at St Andrews

Protocol for the development of the STrengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies

Research output: Contribution to journalArticle

Author(s)

Marty Richardson, Jamie J. Kirkham, Kerry M. Dwan, Derek J. Sloan, Geraint Davies, Andrea Jorgensen

School/Research organisations

Abstract

Introduction: Large sample sizes are often required to detect statistically significant associations between pharmacogenetic markers and treatment response. Meta-analysis may be performed to synthesise data from several studies, increasing sample size and consequently power to detect significant genetic effects. However, performing robust synthesis of data from pharmacogenetic studies is often challenging due to poor reporting of key data in study reports. There is currently no guideline for the reporting of pharmacogenetic studies. The aim of this project is to develop the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline. The STROPS guideline will facilitate the conduct of high-quality meta-analyses and thus improve the power to detect genetic associations.


Methods and analysis:  We will establish a preliminary checklist of reporting items to be considered for inclusion in the guideline. We will then conduct a Delphi survey of key stakeholder groups to gain consensus opinion on which reporting items to include in the final guideline. The Delphi survey will consist of two rounds: the first round will invite participants to score items from the preliminary checklist and to suggest additional relevant items; the second round will provide feedback from the previous round and invite participants to re-score the items. Following the second round, we will summarise the distribution of scores for each item, stratified by stakeholder group. The Steering Committee for the project and representatives from the key stakeholder groups will meet to consider the results of the Delphi survey and to finalise the list of reporting items. We will then draft, pilot-test and publish the STROPS reporting guideline and accompanying explanatory document.


Ethics and dissemination: The University of Liverpool Ethics Committee has confirmed ethical approval for this study (reference: 3586). Dissemination activities will include presenting the reporting guideline at conferences relevant to pharmacogenetic research.

Close

Details

Original languageEnglish
Article numbere030212
Number of pages5
JournalBMJ Open
Volume9
Issue number7
DOIs
Publication statusPublished - 11 Jul 2019

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. A tuberculosis molecular bacterial load assay (TB-MBLA)

    Sabiiti, W., Mtafya, B. A., Alferes De Lima, D., Dombay, E., Baron, V. O., Azam, K., Orascova, K., Sloan, D. J. & Gillespie, S. H., 6 Sep 2019, (Accepted/In press) In : Journal of Visualized Experiments.

    Research output: Contribution to journalArticle

  2. Linezolid for drug-resistant pulmonary tuberculosis

    Singh, B., Cocker, D., Ryan, H. & Sloan, D. J., 20 Mar 2019, In : Cochrane Database of Systematic Reviews. 2019, 3, CD012836.

    Research output: Contribution to journalReview article

  3. Evaluation of the efficacy of two methods for direct extraction of DNA from Mycobacterium tuberculosis sputum

    Ndhlovu, V., Mandala, W., Sloan, D., Kamdolozi, M., Caws, M. & Davies, G., 31 Dec 2018, In : Journal of Infection in Developing Countries. 12, 12, p. 1067-1072 6 p.

    Research output: Contribution to journalArticle

  4. Effect of the duration of antimicrobial exposure on the development of antimicrobial resistance (AMR) for macrolide antibiotics: protocol for a systematic review with a network meta-analysis

    Divala, T. H., Corbett, E. L., Stagg, H. R., Nliwasa, M., Sloan, D. J., French, N. & Fielding, K. L., 23 Dec 2018, In : Systematic Reviews. 7, 9 p., 246.

    Research output: Contribution to journalArticle

  5. CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

    Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G. & Jorgensen, A. L., 20 Nov 2018, In : Systematic Reviews. 7, 15 p., 204.

    Research output: Contribution to journalArticle

Related by journal

  1. Communication skills training for the radiotherapy team to manage cancer patients’ emotional concerns: a systematic review

    van Beusekom, M. M., Cameron, J., Bedi, C., Banks, E. & Humphris, G. M., 20 Apr 2019, In : BMJ Open. 9, 11 p., e025420.

    Research output: Contribution to journalReview article

  2. Participatory governance over research in an academic research network: the case of Diabetes Action Canada

    Willison, D. J., Trowbridge, J., Greiver, M., Keshavjee, K., Mumford, D. & Sullivan, F., Apr 2019, In : BMJ Open. 9, 4, 9 p., e026828.

    Research output: Contribution to journalArticle

  3. Trends in end digit preference for blood pressure and associations with cardiovascular outcomes in Canadian and UK primary care: a retrospective observational study

    Greiver, M., Kalia, S., Voruganti, T., Aliarzadeh, B., Moineddin, R., Hinton, W., Dawes, M., Sullivan, F., Syed, S., Williams, J. & De Lusignan, S., 24 Jan 2019, In : BMJ Open. 9, 1, 11 p., e024970.

    Research output: Contribution to journalArticle

  4. Foundation Year 2 doctors’ reasons for leaving UK medicine: an in-depth analysis of decision-making using semistructured interviews

    Smith, S. E., Tallentire, V. R., Pope, L. M., Laidlaw, A. H. & Morrison, J., 2 Mar 2018, In : BMJ Open. 8, 17 p., e019456.

    Research output: Contribution to journalArticle

ID: 260484510

Top